Glucocorticoid-induced osteoporosis: A clinician's perspective

Clinical Reviews in Bone and Mineral Metabolism

Volumn 2, Issue 2, 2004, Pages 79-90

  Graves III, Leland ^a   Lukert, Barbara P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Fracture risk; Glucocorticoid induced osteoporosis; Management; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM CARBONATE; ERGOCALCIFEROL DERIVATIVE; ETIDRONIC ACID; FLUORIDE SODIUM; GLUCOCORTICOID; NANDROLONE; PAMIDRONIC ACID; PARATHYROID HORMONE; PREDNISONE; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D;

ADULT; CASE REPORT; CLINICAL OBSERVATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG INDUCED DISEASE; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; FRACTURE; GLUCOCORTICOID INDUCED OSTEOPOROSIS; HUMAN; INCIDENCE; LONG TERM EXPOSURE; REVIEW; RISK ASSESSMENT; STEROID THERAPY;

EID: 4143126944     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/bmm:2:2:079     Document Type: Review

References (75)

1. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344-346.
2. Adinoff AD, Hollister JR. 1983 Steroid-induced fractures and bone loss in patients with asthma. N Engl Med 309:265-268.
3. Cooper C, Wickham C. 1990 Rheumatoid arthritis, corticosteroid therapy and fracture of the proximal femur. J Bone Miner Res 5:S109.
4. Michel BA, Bloch DA, Fries JF 1991 Predictors of fracture in early rheumatoid arthritis. J Rheumatol 18:804-808.
5. Dykman TR, Gluck OS, Murphy WA, et al. 1985 Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rhumatic disease. Arthritis Rheum 28:361-368.
6. Ip M, Lam K, Yam L, Kung A, Ng M. 1994 Decreassed bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105:1722-1727.
7. Saag KG, Emkey R, Schnitzer TJ, et al. 1998 Alendronate for the prevention of glucocorticoid-induced osteoporosis. N Engl J Med 339:292-299.
8. Cohen S, Levy RM, Keller M, et al. 1999 Risedronate therapy prevents corticosteroid-induced bone loss: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 42:2309-2318.
9. Reid DM, Hughes R, Laan RF. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. J Bone Miner Res 2000;15:1006-1013.
10. van Everdingen AA, Jacobs JWG, van Reesema DR, et al. Low dose prednisone therapy for patient with early active rheumatoid arthritis: clinical efficacy disease modifying properties and side effects: a double-blind placebo-controlled clinical trial. Ann Intern Med 2002:136:1-12.
11. Michel BA, Bloch DA, Wolfe F, et al. 1993 Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheum 20:1666-1669.
12. Cooper C, Coupland C, Mitchell M. 1995 Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54; 49-52.
13. de Nijs RNJ, Jacobs JWG, Bijlsma JWJ, et al. 2001 Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 40:1375-1383.
14. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000.
15. van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. 2000 Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39:1383-1389.
16. Hall GM, Spector TD, Griffin JA, et al. 1993 The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritic Rheum 36:1510-1516.
17. Kroger H, Honaken R, Saarikoski S, et al. 1994 Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population based study. Ann Rheum Dis 53:18-21.
18. Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook P. 2000 Vertebral fracture risk with long-term corticosteroid therapy. Arch Intern Med 160:2917-2922.
19. Cooper C, Coupland C, Michell M. 1995 Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54:49-52.
20. Baltzan MA, Suissa S, Bauer DC, et al. 1999 Hip fractures attributable to corticosteroid use. Lancet 353:1327
21. LoCascio V, Bonucci E, Imbimbo B, et al. 1984 Bone loss after glucocorticoid therapy. Calcif Tissue Int 36:435.
22. Eastell R, Reid DM, Compston J, et al. 1998 A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 244:271-292.
23. Laan RFJM, Buifs WCAM, van Erning LJT, et al. 1993 Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52:5-9.
24. Reid IR, Evans MC, Wattie DJ, et al. 1992 Bone mineral density of the proximal femur and lumbar spine in glucocoriticoid-treated asthmatic patients. Osteoporosis Int 2:103-105.
25. Ruegesegger P, Medici TC, Anlinker M. 1983 Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. J Clin Pharmacol 25:615-620.
26. Homik JE, Cranney A, Shea B, et al. 1999 A meta-analysis on the use of bisphosphonates in corticosteroid-induced osteoporosis. J Rheumatol 26:1148-1157.
27. Luengo M, Picado C, Del Rio L, et al. 1991 Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46:803-806.
28. Evans SF, Davie MWJ. 2000 Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis 59:269-275.
29. Naganatham V, Jones G, Nash P, et al. 2000 Vertebral fracture risk with long-term corticosteroid therapy. Arch Int Med. 160:2917-2922.
30. Selby PL, Halsey JP, Adams KRH, et al. 2000 Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res. 15:952-956.
31. Adams JS, Wahl TO, Lukert BP. 1981 Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients. Metabolism. 30:217-221.
32. Reid IR, Ibbertson HK. 1986 Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 44:287-290.
33. Colette C, Monnier L, Pares Herbute N, Blotman F, Mirouze J. 1987 Calcium absoption in corticoid treated subjects-effects of a single oral dose of calcitriol. Horm Metab Res 19:335-338.
34. Bikle DD, Halloran BP, Fong L, Seinbach L, Shellito J 1993 Elevated 1,25-dihydroxyvitamin D levels in patient with chronic obstructive pulmonary disease treated with prednisone. J Clin Endocrinol Metab 76:456-461.
35. Rubin MR, Bilezikian JP. 2002 The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis - A re-examination of the evidence. J Clin Endocrinol Metab 87:4033-4041.
36. Montecucco C, Caporali R, Caprotti P, Caprotti M, Notario A. 1992 Sex hormones and bone metabolism in post-menopausal rheumatoid arthritis treated with two different glucocorticoids. J Rheumatol 19:1895-1899.
37. Sakakura M, Takebe K, Nakagawa S. 1975 Inhibition of luteinizing hormone secretion induced by synthetic LHRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40:774-779.
38. Goulking A, Gold E. 1988 Effects of chronic prednisolone treatment on bone resorption and bone composition in intact an ovariectomized rats and in ovariectomized rats receiving β-estrodiol. Endorinology 122:482-487.
39. Lukert BP, Johnson BE, Robinson RG. 1992 Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 7:1063-1069.
40. Hofbauer LC, Gori FRBL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S. 1999 Stimulation of osteoprotegerin ligand an inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389.
41. Sasaki N, Kusano E, Ando Y, Nemoto F, Iimura O, Ito C. 2002 Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone 30:853-858.
42. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. 2000 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest. 102:274-282.
43. Patschan D, Loddenkemper K, Buttgereit F. 2001 Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498-505.
44. Centrella M, McCarthy TL, Canalis EM. 191 Glucocorticoid regulation of transforming growth factor B1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490-4496.
45. Blanquaert F, Pereira RC, Canalis E. 2000 cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblast. Am J Physiol 278:509-515.
46. Cooper MS, Bujalska I, Rabbit EH, Walker EA, Bland R, Sheppard MC. 2001 Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 17:1037-1044.
47. Administration HCF, 42 CFR Part 410, et al. 1998 Medicare program coverage of and payment for bone mass measurements. Federal Register 63:34320-34328.
48. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced osteoporosis. 2001. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503.
49. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis. 1994 Rheum Dis Clin North AM 20:629-651.
50. National Osteoporosis Foundation. 1998 Physician's guide to prevention and treatment of osteoporosis Bellemead, NJ: Excerpta Medica Inc.
51. Eastell R, Reid DM, Compston J, et al. 1998 A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 244:271-292.
52. Sambrook PN, Diamon T, Ferris L, et al. 2001 Corticosteroid induced osteoporosis: guidelines for treatment. Australian Fam Phys 30:793-796.
53. Amin S, LaValley MP, Simms RW, Felson DT. 1999 The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthiris Rheum 42:1740-1751.
54. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P. 2000 Calcium and vitamin d for corticosteroid-induced osteoporosis Cochrane review. In: Cochrane Library, Issue2. Oxford (UK): Update Software.
55. Sambrook PN, Birmingham J, Kelly P, Kempler S, Pocock NA, Eisman JA. 1993 Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752.
56. Reginster JY, Kuntz D, Verdickt W, et al. 1999 Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 9:75-81.
57. Amin S, Lin JM, Simms RW, Felson DT. 2002 The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression. J Bone Miner Res 17:1512-1526.
58. Cauley JA, Cummings SR, Seeley DG, et al. 1993 Effects of thiazide diuretic therapy on bone mass, fractures, and falls: the study of osteoporotic fractures. Ann Intern Med 188:666-673.
59. Adachi J, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E. 2001 Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. Arthritis Rheum 44:202-211.
60. Reid DM, Hughes RA, Laan R, Sacco-Gibson NA, Wenderoth DH. 2000 Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. J Bone Miner Res 15:1006-1012.
61. Wallach S, Reid DM, Hughes RA, et al. 2000 Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277-285.
62. Homik J, Cranney A, Shea B, et al. 2003 Bisphosphonates for steroid induced osteoporosis. Cochrane review. In: Cochrane Library, Issue 4. Oxford (UK): Update Software.
63. Reid IR, King AR, Alexander CJ, Ibbertson HK. 1988 Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1, 1bisphosphonate (APD). Lancet 1:143-146.
64. Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP. 2001 Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, and infusion given once every 3 months, and calcium alone. J Bone Miner Res 16:104-112.
65. Hall GM, Daniels M, Dolye DV, et al. 1994 Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients with and without steroids. Arthritis Rheum. 37:1499-1505.
66. Lukert BP, Johnson BE, Robinson RG. 1992 Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone miner Res. 7:1063-1069.
67. Writing Group for the Womens Health Initiative Investigator. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321-333.
68. Ettinger B, Black DM, Mitlak BH, et al. 1999 Reduction in vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcome of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637-645.
69. Crawford BAL, Liu PY, Kean MT, Bleasel JF, Handelsman DJ. 2003 Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoids. J Clin Endocrinol Metab 88:3167-3176.
70. Drinkwater BL, Nilson K, Ott S, Chesnut CH. 1986 Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med 311:277-281.
71. Cranney A, Welch V, Adachi JD, et al. 2003 Calcitonin for preventing and treating corticosteroid-induced osteoporosis. Cochrane review. In: Cochrane Library, Issue 4. Oxford (UK): Update Software.
72. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. 1998 Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis results of a randomized controlled clinical trial. J Clin Invest 102:1627-1633.
73. Lane NE, Sanchez S, Modin G, Genant HK, Pierini E, Arnaud CD. 2000 Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled trial. J Bone Miner Res 15:944-951.
74. Lems WF, Jacobs WG, Bijlsma JW, et al. 1997 Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis. Osteoporosis Int 7:575-582.
75. Lems WF, Jacobs JW, Bijlsma JW, et al. 1997 Is the addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid-induced osteoporosis? Ann Rheum Dis 56:357-363.